Milestone Pharmaceuticals Inc. (MIST) Tops Q3 EPS by 2c

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q3 EPS of ($0.14), $0.02 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.

You May Also Be Interested In

• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
• Abbott (ABT) Declares $0.63 Quarterly Dividend; 2.9% Yield
• Jefferies says restaurant traffic weakened in May